Because the supernatant of IL-32 siRNA-transfected normal human bronchial epithelial cells increased in vitro angiogenesis of human umbilical vein endothelial cells, IL-32 might be also an inhibitor of airway remodeling in asthma patients [61]. Here, IL32 is linked to asthma.